Created in 1997 as a result of the pioneering efforts of its founders in implementing one of the first antiretroviral (ARV) access programs in the world, Axios continues to break new ground in the design and implementation of one-of-a-kind sustainable market access solutions to drive access to healthcare across Africa, Asia, the Middle East, Latin America and Europe.

Axios works closely with drug manufacturers and healthcare companies to strengthen their presence in emerging markets, while ensuring that patient outcomes are met. This unique approach, which blends business and patient interests, is the bread and butter of Axios’ access philosophy and comprehensive services.